Latest Breaking News On - Professor gideon hirschfield - Page 1 : vimarsana.com

Study explores potential target to treat liver disease

Study explores potential target to treat liver disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

David adamsGideon hirschfieldGideonm hirschfieldBirmingham biomedical research center inflammatory liver diseaseUniversity of birminghamPhepatology communicationsToronto centerAutoimmune liver disease researchUniversity of birmingham institute immunologyProfessor david adamsChris westonAssociate professorBiomedical research centerInflammatory liver diseaseClinical investigatorProfessor gideon hirschfield

Pliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in an Oral Late-Breaking Presentation at The Liver Meeting® 2023

Interim results from INTEGRIS-PSC to be featured in an oral presentation on Monday, November 13SOUTH SAN FRANCISCO, Calif., Oct. 19, 2023 Pliant Therapeutics, Inc. , a clinical-stage.

United statesJohanna schaubChristopher keenanMichael traunerRichard pencekTerry hornerGideonm hirschfieldChrisn barnesHardeane achneckChristoph schrammGideon hirschfieldTheresa thuenerKrisv kowdleyAnnie clarkChristopherl bowlusPliant therapeutics inc

CymaBay Therapeutics, Inc (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

Sujal shahKristen kluskaHarish shantharamJay olsonAndy hsiehPatrick dolezalLewis stuartCharles mcwherterRaymond jamesYasmeen rahimiPaul quinlanEd arceMayank mamtaniPiper sandlerSteve seedhouseChuck mcwherter

Improved Transplant-Free Survival Observed with Obeticholic Acid in People with PBC Published in Gastroenterology

Improved Transplant-Free Survival Observed with Obeticholic Acid in People with PBC Published in Gastroenterology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesM michelle berreyTerry hornerGideon hirschfieldUniversity of torontoIntercept pharmaceuticals incWarfarinthe international normalized ratioResearch developmentWall streetProfessor gideon hirschfieldTerry horner chairAutoimmune liver diseaseChief medical officerAmerican associationLiver diseases

Intercept Pharma (ICPT) Announces Improved Transplant-Free Survival Observed with Obeticholic Acid in People with PBC Published in Gastroenterology

Intercept Pharma (ICPT) Announces Improved Transplant-Free Survival Observed with Obeticholic Acid in People with PBC Published in Gastroenterology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesM michelle berreyTerry hornerGideon hirschfieldUniversity of torontoIntercept pharmaceuticals incResearch developmentProfessor gideon hirschfieldTerry horner chairAutoimmune liver diseaseChief medical officerAmerican associationLiver diseasesNorth america